NCT04492150

Brief Summary

Induction of labor, is one of the most common obstetric procedures done routinely in modern obstetrics. For example, in USA, 23% of pregnant women in 2012 (about 1 million) underwent an induction of labor. However, accurate data about percentage of women undergoing induction of labor in Egypt is not accurately known. One of the recent research era in current obstetrics is the optimal intravenous (IV) hydration of the pregnant women in labor.Current evidences available in our hands, suggest that maternal hydration appears to fasten labor progress and enhance the action of oxytocin, if the later is used for augmentation. However, the addition of glucose supplementation to this IV hydration to enhance uterine contraction, as a matter of safety and efficacy, is controversial

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
476

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 30, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2020

Completed
Last Updated

July 30, 2020

Status Verified

July 1, 2020

Enrollment Period

1 year

First QC Date

July 27, 2020

Last Update Submit

July 27, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • the duration of labor

    the duration from the beginning of active labor (cervical exam between 3 and 5 cm with regular uterine contractions) to fetal delivery, reported in minutes.

    24 hours

Secondary Outcomes (1)

  • Rate of cesarean sections

    24 hours

Study Arms (2)

study group

EXPERIMENTAL

women who will receive 250 mL/hour of dextrose 5% with normal saline in a 1:1 ratio.

Drug: Dextrose 5%/Nacl 0.3% Inj_#3Drug: Saline

control group

ACTIVE COMPARATOR

women who will receive 250 mL/hour of normal saline for the whole duration of induction

Drug: Saline

Interventions

250 mL/hour of dextrose 5% intravenous drip

study group
SalineDRUG

250 mL/hour of normal saline intravenous drip

control groupstudy group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult (\>18 years) multiparous women
  • Late Term Pregnancy ( gestational Age Between 40-42 weeks)
  • Uncomplicated singleton pregnancy with cephalic presentation.
  • Favorable cervix for induction (Bishop score\<6) without ruptured membranes.

You may not qualify if:

  • Women with chronic diseases or complicated pregnancy; gestational and pre gestational ( type 1 \& 2)diabetes, preeclampsia and\\or renal and\\or maternal heart diseases.
  • Non-cephalic presentations, multiple pregnancies, or cervix unfavorable for induction.
  • Other indications for cesarean delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez canal University

Ismailia, Egypt

RECRUITING

MeSH Terms

Interventions

GlucoseSodium Chloride

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydratesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Zakia M Ibraheim, MD

    Professor of Gynecology and Obstetrics

    STUDY CHAIR
  • Mariam L Mohammed, MD

    Assistant Professor of Gynecology and Obstetrics

    STUDY DIRECTOR
  • Hanan M Ghoneim, MD

    Assistant Professor of Gynecology and Obstetrics

    STUDY DIRECTOR
  • Ahmed M Abbas, MD

    Assistant Professor of Gynecology and Obstetrics

    STUDY DIRECTOR

Central Study Contacts

Salwa H Tammam, M. B. B. Ch

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

July 27, 2020

First Posted

July 30, 2020

Study Start

September 9, 2019

Primary Completion

September 10, 2020

Study Completion

October 10, 2020

Last Updated

July 30, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations